Corrales, NM – October 5, 2017 – Indica Labs Inc headquartered in Corrales, New Mexico, is pleased to announce the selection of the newly developed
Portland, OR – September 29, 2017 – MolecularMD, a provider of molecular and tissuebased clinical trial assays and diagnostics for oncology based drug development programs,
Dr. Keith J. Kaplan | July 31, 2017 | Source: Indica Labs Indica Labs announced today that Douglas Bowman has been appointed Vice President, Pharma
Indica Labs Appoints a Vice President, Pharma Services Read More »
ABSTRACT Although availability of automated platforms has proliferated, there is no standard practice for computer-assisted generation of scores for mRNA in situ hybridization (ISH) visualized
Abstract We conducted a first-in-human study of intravenous delivery of a single dose of autologous T cells redirected to the epidermal growth factor receptor variant
Corrales, NM – April 24th 2017 – Indica Labs proudly announces its breakthrough HALO® Deep Learning technology excelled in the CameLyon17 diagnostic image analysis competition.
HALO® Deep Learning Technology Awarded for Automated Breast Cancer Metastasis Staging Read More »
Abstract Autoantigen-specific immunological tolerance represents a central objective for prevention of type 1 diabetes (T1D). Previous studies demonstrated mucosal antigen administration results in expansion of
Abstract Over the past few decades, clinical and preclinical studies have clearly demonstrated the role of mucins in tumor development. It is well established that
Molecular Pathways: Mucins and Drug Delivery in Cancer Read More »
Abstract Inactivating mutations in the insulin receptor results in extreme insulin resistance. The resulting hyperglycemia is very difficult to treat, and patients are at risk
Glucagon receptor inhibition normalizes blood glucose in severe insulin-resistant mice Read More »
Genetic disruption or pharmacologic inhibition of glucagon signaling effectively lowers blood glucose but results in compensatory glucagon hypersecretion involving expansion of pancreatic α-cell mass. Ben-Zvi
